2026-08-12 · By SEPT AI
U.S. equities closed in the red on Wednesday, with the major averages extending their recent slide as the Fear & Greed Index sank to 27, firmly in “Fear” territory. A lack of fresh catalysts and lingering concerns over the economic outlook kept buyers on the sidelines, while a flurry of earnings reports and corporate news drove outsized moves in individual names.
The Dow Jones Industrial Average, tracked by the DIA ETF, slipped 0.35% to close at $537.12, after touching a session high of $539.18. The S&P 500, via the SPY, fell 0.29% to $772.47, while the tech-heavy Nasdaq-100, as measured by the QQQ, dropped 0.46% to $723.70. Small caps fared slightly better, with the IWM declining just 0.11% to $302.68.
The broad-based decline was led by technology and consumer discretionary names, which weighed heavily on the Nasdaq. Defensive sectors provided some cushion, but the overall tone was cautious. The Fear & Greed Index at 27 signals that investors are increasingly risk-averse, a sentiment reflected in the day’s low volume and narrow trading ranges. With no major economic data releases on the calendar, traders focused on corporate earnings and forward guidance.
The day’s most dramatic moves were concentrated in small-cap and micro-cap names, driven by a mix of earnings surprises, capital raises, and regulatory filings.
Boxlight Corp. (BOXL) surged 72.40% to $7.87 on massive volume of over 42 million shares, though no specific catalyst was immediately apparent in the data. BANL jumped 50.62% to $6.10, while BQ climbed 37.05% to $1.23 on the heaviest volume of the session at nearly 87 million shares.
On the downside, NBIZ cratered 51.51% to $5.31, and OFAL tumbled 46.46% to $1.36. HYLN fell 23.58% to $3.89, and SMCZ dropped 23.17% to $3.35.
Several stocks moved on corporate actions. Allogene Therapeutics (ALLO) slid after filing a prospectus for a $500 million stock offering, a classic dilution catalyst. Similarly, Cue Biopharma (CUE) fell after filing for the resale of over 1.5 million shares tied to a July private placement. Outlook Therapeutics (OTLK) also traded lower after announcing a proposed public offering.
Virgin Galactic (SPCE) was a notable decliner, diving after its Q2 earnings print. The company disclosed that its first commercial spaceflight has been pushed to February 2027, though it also provided an upbeat outlook on reaching positive quarterly cash flow within 2027 and commencing flight tests in October 2026. The stock initially fell but later recovered some ground.
Cisco Systems (CSCO) was the standout after the bell, delivering a fiscal Q4 double beat and strong guidance, which the company attributed to a “networking supercycle.” The stock was trading higher in extended hours.
Key Earnings: Mixed Results Across the Board
The earnings calendar was packed, with results ranging from stellar to disappointing.
Amcor (AMCR) beat estimates, posting EPS of $1.23 versus the $1.20 consensus. Coherent (COHR) delivered a significant beat, with EPS of $1.74 topping the $1.43 estimate. Brinker International (EAT) reported revenue of $6.15 billion, though EPS data was not provided. Trimble (TRMB) crushed expectations with EPS of $3.60 versus the $0.65 estimate, sending shares higher. Bio-Techne (TECH) also beat, with EPS of $0.52 versus $0.46.
However, EnerSys (ENS) missed on the bottom line, reporting EPS of $2.23 versus the $2.82 estimate, though the company raised its dividend and shares traded higher. Leslie’s (LESL) plunged after reporting worse-than-expected Q3 results and withdrawing its FY26 guidance. Pershing Square (PS) missed estimates on both EPS and revenue, with an adjusted loss of $0.11 per share versus a $0.12 profit expected. comScore (SCOR) also disappointed, guiding FY26 sales below consensus.
On the positive side, Liftoff Mobile (LFTO) issued strong FY2026 sales guidance of $870 million to $880 million, above the $855.59 million estimate, sending shares higher. CuriosityStream (CURI) rallied after beating Q2 expectations and raising its full-year sales guidance. Fossil Group (FOSL) jumped on a Q2 beat and an upward revision to its FY26 outlook. Usio (USIO) also gained after raising its guidance.
Notable insider buying activity was detected across several names, signaling confidence from corporate insiders.
KKR & Co. (KKR) received a STRONG_BUY signal with a score of 3, driven by 9 insider purchases totaling $34.8 million. Taiwan Semiconductor (TSM) also earned a STRONG_BUY rating, with 77 insider buys worth $1.2 million. Erie Indemnity (ERIE) and MercadoLibre (MELI) each scored a STRONG_BUY, with insider purchases of $1.4 million and $1.3 million, respectively.
Other notable insider buying included Ryan Specialty Group (RYAN) with 9 buys totaling $5.6 million, and SLR Investment Corp. (SLRC) with 8 buys worth $3.8 million.
Bitcoin and Ethereum traded in a narrow range with no major headlines, as the broader risk-off tone in equities kept crypto markets subdued.
Investors will turn their attention to Thursday’s economic calendar, which includes weekly jobless claims and July retail sales data. The retail sales report will be closely watched for signs of consumer spending resilience. Additionally, more earnings are on deck, with Cisco’s after-hours report likely to set the tone for tech stocks. The market’s ability to hold above recent support levels will be tested as the Fear & Greed Index remains in deeply fearful territory.
Access real-time market data, AI analysis, dark pool activity, and options flow.
Start Free Trial